2007-09-28T09:00:00
Transparent mechanisms for deciding on the use of high-cost drugs for rare disorders are needed, says Michael Sobanja
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud